What is Carbidopa-Entacapone-Levodopa?
Category: Prescription Drugs
Most popular types: Stalevo Stalevo 100 Stalevo 150 Show all
The combination of levodopa, carbidopa, and entacapone is used for Parkinson's Disease. Levodopa is the precursor to dopamine, carbidopa slows the breakdown of levodopa, while entacapone improves the efficacy of levodopa.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Parkinson's disease | 3260 | 309 | |
| Stiffness/spasticity | 26 | 20 | |
| Increase effect of another treatment | 15 | 14 | |
| Improve mobility | 5 | 4 | |
| Tremor(s) | 5 | 1 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 32 | |
| Moderate | 73 | |
| Mild | 80 | |
| None | 139 |
Commonly reported side effects and conditions associated with Carbidopa-Entacapone-Levodopa
| Side effect | Patients | Percentage |
|---|---|---|
| Jerky movements | 37 | |
| Nausea | 17 | |
| Cramps in legs | 8 | |
| Dry mouth | 8 | |
| Fatigue | 7 | |
| Weight gain | 6 |
Why patients stopped taking Carbidopa-Entacapone-Levodopa
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Side effects too severe | 77 | |
| Doctor's advice | 71 | |
| Did not seem to work | 43 | |
| Other | 41 | |
| Expense | 21 | |
| Personal research | 8 | |
| Change in health plan coverage | 3 | |
| Course of treatment ended | 1 |
Duration
Stopped taking Carbidopa-Entacapone-Levodopa
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 28 | |
| 1 - 6 months | 57 | |
| 6 months - 1 year | 36 | |
| 1 - 2 years | 22 | |
| 2 - 5 years | 48 | |
| 5 - 10 years | 14 | |
| 10 years or more | 6 |
What people switch to and from
Patients started taking Carbidopa-Entacapone-Levodopa after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Carbidopa-Levodopa (Sinemet) | 39 | |
| Ropinirole (Requip) | 8 | |
| Carbidopa Levodopa ER (Rytary XR) | 3 | |
| Pramipexole (Mirapex) | 3 | |
| Amantadine (Symmetrel) | 2 |
Patients stopped taking Carbidopa-Entacapone-Levodopa and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Carbidopa-Levodopa (Sinemet) | 21 | |
| Carbidopa Levodopa ER (Rytary XR) | 16 | |
| Entacapone (Comtan) | 5 | |
| Carbidopa-Levodopa CR (Sinemet CR) | 3 | |
| Pramipexole (Mirapex) | 3 |
Last updated: